Advanced researches on proteomics in leukemia
- VernacularTitle:蛋白质组学在白血病中的研究进展
- Author:
Zesong YANG
;
Jianbin CHEN
- Publication Type:Journal Article
- From:
Chinese Journal of Tissue Engineering Research
2007;0(07):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE: To summarize the techniques, methods and applications of proteomics in leukemia. DATA SOURCES: A computer-based online search of Medline database between January 2001 and March 2006 was undertaken to identify relevant articles published in English by using the keywords of "proteomics, leukemia". Meanwhile, Chinese articles published from January 2001 to March 2006 were searched in Weipu database, with the keywords of "proteomics, leukemia". STUDY SELECTION: The data were checked firstly, and the articles with repetitive contents were deleted, and then the full-texts of the rest articles in recent 5 years were obtained. Inclusive criteria:①original works about proteomics;②original works about leukemia;③original works about the relation between proteomics and leukemia. Exclusive criteria: repetitive studies and Meta analysis. DATA EXTRACTION: Totally 107 articles about the proteomics and leukemia were collected, and the repetitive or similar studies were excluded, finally 30 articles were involved, including 11 about the proteomics and 19 about the advancement of proteomics and leukemia. DATA SYNTHESIS: Proteomics is a novel science that is aimed to study proteome by various techniques and to analyze the cornpositions, expressions and modifications of protein entirely. The decussation of proteomics, genomics and bioinformatics has formed the mode of the systemic bioresearch. Leukemia, the common malignant tumor in the hematological system, is prone to be multi-drug resistant after chemotherapy, whose mechanism is not clear. Blood proteome consists of all the protein expressed in the hematological system, and investigates the mechanism of proliferation, differentiation and abnormal transformation of leukemic cells, as well as the early diagnosis and treatment of leukemia. Additionally, it illuminates the correlation of protein's expression with the occurrence and development of leukemia, so as to provide the scientific evidences for searching new drugs and diagnosing prognosis. Proteomics will help a lot in elucidating the pathogenesis of leukemia, the prognostic judgment, the choice of chemotherapy drugs, and the individualized treatment. CONCLUSION: Proteomics can provide rationale for the individualized treatment and the prognostic judgment of leukemia.
